225 related articles for article (PubMed ID: 33953586)
1. Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease.
Liang XY; Hong FF; Yang SL
Diabetes Metab Syndr Obes; 2021; 14():1871-1883. PubMed ID: 33953586
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside alleviates alcoholic fatty liver disease by suppressing oxidative stress.
Jiang ZB; Gao J; Chai YH; Li W; Luo YF; Chen YZ
Kaohsiung J Med Sci; 2021 Aug; 37(8):718-729. PubMed ID: 33973356
[TBL] [Abstract][Full Text] [Related]
3. [Tanshinone Ⅱ_A inhibits ferroptosis via Nrf2 signaling pathway to protect liver in rats of non-alcoholic fatty liver disease].
Qin Z; Zhou M
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1611-1620. PubMed ID: 38621946
[TBL] [Abstract][Full Text] [Related]
4. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV protects LO2 cells from oxidative damage caused by radiation-induced bystander effect through Akt/Nrf2 pathway.
Wan D; Zhu Z; Zhou J; Deng Z; Lei P; Liu Q; Sun X; Huang B
Toxicol Res (Camb); 2023 Aug; 12(4):635-647. PubMed ID: 37663802
[TBL] [Abstract][Full Text] [Related]
6. [Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats].
Wang HY; Liang CM; Cui JW; Pan L; Hu H; Fang HJ
Zhen Ci Yan Jiu; 2019 Mar; 44(3):189-94. PubMed ID: 30945501
[TBL] [Abstract][Full Text] [Related]
7. Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model.
Xu Z; Lin S; Tong Z; Chen S; Cao Y; Li Q; Jiang Y; Cai W; Tong Y; Zahra BS; Wang P
J Ethnopharmacol; 2022 Mar; 285():114873. PubMed ID: 34848360
[TBL] [Abstract][Full Text] [Related]
8. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway.
Liu Y; Xu W; Zhai T; You J; Chen Y
Acta Pharm Sin B; 2019 Jul; 9(4):745-757. PubMed ID: 31384535
[TBL] [Abstract][Full Text] [Related]
9. Idebenone reduces sepsis-induced oxidative stress and apoptosis in hepatocytes via RAGE/p38 signaling.
Gou T; Jin X; Xia J
Ann Transl Med; 2022 Dec; 10(24):1363. PubMed ID: 36660726
[TBL] [Abstract][Full Text] [Related]
10. Hepatoprotective effects of Methyl ferulic acid on alcohol-induced liver oxidative injury in mice by inhibiting the NOX4/ROS-MAPK pathway.
Li C; Li L; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW
Biochem Biophys Res Commun; 2017 Nov; 493(1):277-285. PubMed ID: 28890346
[TBL] [Abstract][Full Text] [Related]
11. Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression.
Zhang N; Qu Y; Qin B
Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1125-1136. PubMed ID: 33721354
[TBL] [Abstract][Full Text] [Related]
12. Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury.
Wang D; Liu Y; Zhong G; Wang Y; Zhang T; Zhao Z; Yan X; Liu Q
J Ethnopharmacol; 2017 May; 204():67-76. PubMed ID: 28389356
[TBL] [Abstract][Full Text] [Related]
13. Omarigliptin protects against nonalcoholic fatty liver disease by ameliorating oxidative stress and inflammation.
Li Z; Wang H; Wu K; Zhang L
J Biochem Mol Toxicol; 2021 Dec; 35(12):e22914. PubMed ID: 34533252
[TBL] [Abstract][Full Text] [Related]
14. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
15. Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.
Sun R; Zhang A; Ge Y; Gou J; Yin T; He H; Wang Y; Zhang G; Kong J; Shang L; Tao X; Zhang Y; Tang X
Expert Opin Drug Deliv; 2020 Sep; 17(9):1305-1320. PubMed ID: 32538226
[TBL] [Abstract][Full Text] [Related]
16. [Psoralen and isopsoralen improve lipid metabolism disorder via inhibition of NF-κB activation in LO2 cells].
Zhou LS; Yan SQ; Xiong XL; Huang J; Qin H; Zhang LL; Zhang LL; Tang JQ
Zhongguo Zhong Yao Za Zhi; 2019 May; 44(10):2118-2123. PubMed ID: 31355570
[TBL] [Abstract][Full Text] [Related]
17. Effect of astragaloside IV and salvianolic acid B on antioxidant stress and vascular endothelial protection in the treatment of atherosclerosis based on metabonomics.
Kong XL; Lyu Q; Zhang YQ; Kang DF; Li C; Zhang L; Gao ZC; Liu XX; Wu JB; Li YL
Chin J Nat Med; 2022 Aug; 20(8):601-613. PubMed ID: 36031232
[TBL] [Abstract][Full Text] [Related]
18. Lycium barbarum Polysaccharides Promotes Mitochondrial Biogenesis and Energy Balance in a NAFLD Cell Model.
Zhang YN; Guo YQ; Fan YN; Tao XJ; Gao QH; Yang JJ
Chin J Integr Med; 2022 Nov; 28(11):975-982. PubMed ID: 34874519
[TBL] [Abstract][Full Text] [Related]
19. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
[TBL] [Abstract][Full Text] [Related]
20. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
Tian X; Xiong Q; Chen L; Wen JR; Ru Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
[No Abstract] [Full Text] [Related]
[Next] [New Search]
